|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
2
|
Dušek L, Mužík J, Malúšková D, Májek O,
Pavlík T, Koptíková J, Gregor J, Brabec P and Abrahámová J:
Epidemiology of screening-targeted cancers according to new data of
the Czech National Cancer Registry. Klin Onkol. 27(Suppl 2): 19–39.
2014.In Czech. View Article : Google Scholar
|
|
3
|
Rosenberg AR, Kroon L, Chen L, Li CI and
Jones B: Insurance status and risk of cancer mortality among
adolescents and young adults. Cancer. Dec 9–2014.Epub ahead of
print. PubMed/NCBI
|
|
4
|
Zhang X, Hu S, Zhang X, Wang L, Zhang X,
Yan B, Zhao J, Yang A and Zhang R: MicroRNA-7 arrests cell cycle in
G1 phase by directly targeting CCNE1 in human hepatocellular
carcinoma cells. Biochem Biophys Res Commun. 443:1078–1084. 2014.
View Article : Google Scholar
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang H, Cai K, Wang J, Wang X, Cheng K,
Shi F, Jiang L, Zhang Y and Dou J: MiR-7, inhibited indirectly by
lincRNA HOTAIR, directly inhibits SETDB1 and reverses the EMT of
breast cancer stem cells by downregulating the STAT3 pathway. Stem
Cells. 32:2858–2868. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiang L, Liu X, Chen Z, Jin Y, Heidbreder
CE, Kolokythas A, Wang A, Dai Y and Zhou X: MicroRNA-7 targets
IGF1R (insulin-like growth factor 1 receptor) in tongue squamous
cell carcinoma cells. Biochem J. 432:199–205. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kong D, Piao YS, Yamashita S, Oshima H,
Oguma K, Fushida S, Fujimura T, Minamoto T, Seno H, Yamada Y, et
al: Inflammation-induced repression of tumor suppressor miR-7 in
gastric tumor cells. Oncogene. 31:3949–3960. 2012. View Article : Google Scholar
|
|
9
|
Li J, Zheng Y, Sun G and Xiong S:
Restoration of miR-7 expression suppresses the growth of Lewis lung
cancer cells by modulating epidermal growth factor receptor
signaling. Oncol Rep. 32:2511–2516. 2014.PubMed/NCBI
|
|
10
|
Fang Y, Xue JL, Shen Q, Chen J and Tian L:
MicroRNA-7 inhibits tumor growth and metastasis by targeting the
phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
Hepatology. 55:1852–1862. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Saydam O, Senol O, Würdinger T, Mizrak A,
Ozdener GB, Stemmer-Rachamimov AO, Yi M, Stephens RM, Krichevsky
AM, Saydam N, et al: miRNA-7 attenuation in Schwannoma tumors
stimulates growth by upregulating three oncogenic signaling
pathways. Cancer Res. 71:852–861. 2011. View Article : Google Scholar :
|
|
12
|
Liu S, Zhang P, Chen Z, Liu M, Li X and
Tang H: MicroRNA-7 downregulates XIAP expression to suppress cell
growth and promote apoptosis in cervical cancer cells. FEBS Lett.
587:2247–2253. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Salzman J, Gawad C, Wang PL, Lacayo N and
Brown PO: Circular RNAs are the predominant transcript isoform from
hundreds of human genes in diverse cell types. PLoS One.
7:e307332012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hansen TB, Wiklund ED, Bramsen JB,
Villadsen SB, Statha AL, Clark SJ and Kjems J: miRNA-dependent gene
silencing involving Ago2-mediated cleavage of a circular antisense
RNA. EMBO J. 30:4414–4422. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hsu MT and Coca-Prados M: Electron
microscopic evidence for the circular form of RNA in the cytoplasm
of eukaryotic cells. Nature. 280:339–340. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cocquerelle C, Mascrez B, Hétuin D and
Bailleul B: Mis-splicing yields circular RNA molecules. FASEB J.
7:155–160. 1993.PubMed/NCBI
|
|
20
|
Jeck WR, Sorrentino JA, Wang K, Slevin MK,
Burd CE, Liu J, Marzluff WF and Sharpless NE: Circular RNAs are
abundant, conserved, and associated with ALU repeats. RNA.
19:141–157. 2013. View Article : Google Scholar :
|
|
21
|
Jeck WR and Sharpless NE: Detecting and
characterizing circular RNAs. Nat Biotechnol. 32:453–461. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang XO, Wang HB, Zhang Y, Lu X, Chen LL
and Yang L: Complementary sequence-mediated exon circularization.
Cell. 159:134–147. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vicens Q and Westhof E: Biogenesis of
Circular RNAs. Cell. 159:13–14. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liang D and Wilusz JE: Short intronic
repeat sequences facilitate circular RNA production. Genes Dev.
28:2233–2247. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Danan M, Schwartz S, Edelheit S and Sorek
R: Transcriptome-wide discovery of circular RNAs in Archaea.
Nucleic Acids Res. 40:3131–3142. 2012. View Article : Google Scholar :
|
|
26
|
Wilusz JE and Sharp PA: Molecular biology.
A circuitous route to noncoding RNA. Science. 340:440–441. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guo JU, Agarwal V, Guo H and Bartel DP:
Expanded identification and characterization of mammalian circular
RNAs. Genome Biol. 15:4092014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang PL, Bao Y, Yee MC, Barrett SP, Hogan
GJ, Olsen MN, Dinneny JR, Brown PO and Salzman J: Circular RNA is
expressed across the eukaryotic tree of life. PLoS One.
9:e908592014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ghosal S, Das S, Sen R, Basak P and
Chakrabarti J: Circ2Traits: A comprehensive database for circular
RNA potentially associated with disease and traits. Front Genet.
4:2832013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen CY and Sarnow P: Initiation of
protein synthesis by the eukaryotic translational apparatus on
circular RNAs. Science. 268:415–417. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kato M, Han TW, Xie S, Shi K, Du X, Wu LC,
Mirzaei H, Goldsmith EJ, Longgood J, Pei J, et al: Cell-free
formation of RNA granules: Low complexity sequence domains form
dynamic fibers within hydrogels. Cell. 149:753–767. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ledford H: Circular RNAs throw genetics
for a loop. Nature. 494:4152013. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Maqbool R, Ismail R and Hussain M:
Mutations in microRNA genes and their binding sites are
infrequently associated with human colorectal cancer in the
Kashmiri population. MicroRNA. 2:219–224. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Macha MA, Seshacharyulu P, Krishn SR, Pai
P, Rachagani S, Jain M and Batra SK: MicroRNAs (miRNAs) as
biomarker(s) for prognosis and diagnosis of gastrointestinal (GI)
cancers. Curr Pharm Des. 20:5287–5297. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M,
et al: Human microRNA genes are frequently located at fragile sites
and genomic regions involved in cancers. Proc Natl Acad Sci USA.
101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar :
|
|
37
|
Yao J, Liang L, Huang S, Ding J, Tan N,
Zhao Y, Yan M, Ge C, Zhang Z, Chen T, et al: MicroRNA-30d promotes
tumor invasion and metastasis by targeting Galphai2 in
hepatocellular carcinoma. Hepatology. 51:846–856. 2010.PubMed/NCBI
|
|
38
|
Ma C, Qi Y, Shao L, Liu M, Li X and Tang
H: Downregulation of miR-7 upregulates Cullin 5 (CUL5) to
facilitate G1/S transition in human hepatocellular carcinoma cells.
IUBMB Life. 65:1026–1034. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
Stock AM, Hahn SA, Troost G, Niggemann B,
Zänker KS and Entschladen F: Induction of pancreatic cancer cell
migration by an autocrine epidermal growth factor receptor
activation. Exp Cell Res. 326:307–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ribeiro FA, Noguti J, Oshima CT and
Ribeiro DA: Effective targeting of the epidermal growth factor
receptor (EGFR) for treating oral cancer: A promising approach.
Anticancer Res. 34:1547–1552. 2014.PubMed/NCBI
|
|
41
|
Tomao F, Di Tucci C, Imperiale L, Boccia
SM, Marchetti C, Palaia I, Muzii L and Panici PB: Cervical cancer:
Are there potential new targets? An update on preclinical and
clinical results. Curr Drug Targets. 15:1107–1120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ma D, Hovey RL, Zhang Z, Fye S, Huettner
PC, Borecki IB and Rader JS: Genetic variations in EGFR and ERBB4
increase susceptibility to cervical cancer. Gynecol Oncol.
131:445–450. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Nogueira-Rodrigues A, Moralez G,
Grazziotin R, Carmo CC, Small IA, Alves FV, Mamede M, Erlich F,
Viegas C, Triginelli SA, et al: Phase 2 trial of erlotinib combined
with cisplatin and radiotherapy in patients with locally advanced
cervical cancer. Cancer. 120:1187–1193. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Van Themsche C, Chaudhry P, Leblanc V,
Parent S and Asselin E: XIAP gene expression and function is
regulated by autocrine and paracrine TGF-beta signaling. Mol
Cancer. 9:2162010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gagnon V, Van Themsche C, Turner S,
Leblanc V and Asselin E: Akt and XIAP regulate the sensitivity of
human uterine cancer cells to cisplatin, doxorubicin and taxol.
Apoptosis. 13:259–271. 2008. View Article : Google Scholar
|
|
46
|
Yang WT and Zheng PS: Promoter
hypermethylation of KLF4 inactivates its tumor suppressor function
in cervical carcinogenesis. PLoS One. 9:e888272014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yang WT and Zheng PS: Krüppel-like factor
4 functions as a tumor suppressor in cervical carcinoma. Cancer.
118:3691–3702. 2012. View Article : Google Scholar
|
|
48
|
Burd CE, Jeck WR, Liu Y, Sanoff HK, Wang Z
and Sharpless NE: Expression of linear and novel circular forms of
an INK4/ARF-associated non-coding RNA correlates with
atherosclerosis risk. PLoS Genet. 6:e10012332010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lukiw WJ: Circular RNA (circRNA) in
Alzheimer’s disease (AD). Front Genet. 4:3072013. View Article : Google Scholar
|
|
50
|
Hansen TB, Kjems J and Damgaard CK:
Circular RNA and miR-7 in cancer. Cancer Res. 73:5609–5612. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kosik KS: Molecular biology: Circles
reshape the RNA world. Nature. 495:322–324. 2013.PubMed/NCBI
|
|
52
|
AbouHaidar MG, Venkataraman S, Golshani A,
Liu B and Ahmad T: Novel coding, translation, and gene expression
of a replicating covalently closed circular RNA of 220 nt. Proc
Natl Acad Sci USA. 111:14542–14547. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ashwal-Fluss R, Meyer M, Pamudurti NR,
Ivanov A, Bartok O, Hanan M, Evantal N, Memczak S, Rajewsky N and
Kadener S: circRNA biogenesis competes with pre-mRNA splicing. Mol
Cell. 56:55–66. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Perkel JM: Assume nothing: The tale of
circular RNA. Biotechniques. 55:55–57. 2013.PubMed/NCBI
|
